A 12-week, Multicentric Study to Evaluate the Safety and Efficacy of Bisoprolol in Filipino Hypertensive Subjects With Diabetes

NCT01190436 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Bisoprolol

Sponsor

Merck KGaA, Darmstadt, Germany

Collaborators

[object Object]